Adipocyte differentiation is strongly associated with obesity, which causes metabolic disorders. In this study, we investigated the inhibitory effects of widdrol on 3T3-L1 preadipocyte growth and differentiation. Widdrol decreased lipid droplet accumulation and down-regulated adipogenic transcription factors such as C/EBPα, C/EBPβ, and PPARγ. Widdrol blocked preadipocyte proliferation and differentiation through the inhibition of mitotic clonal expansion, which was accompanied by the failure of degradation of p21, a cyclin-dependent kinase inhibitor. Cell-cycle analysis clearly indicated that widdrol actively induces cell-cycle arrest at the G1-S phage transition, causing cells to remain in the preadipocyte state. Moreover, widdrol increased p21 expression and inhibited Rb phosphorylation in preadipocyte incubated in a hormone medium. Therefore, these findings clearly suggest that widdrol blocks preadipocyte growth and differentiation through the inhibition of mitotic clonal expansion by p21-and Rb-dependent G1 arrest and can be developed as a potent anti-adipogenic agent for reducing obesity.
Currently, obesity is a direct cause of diverse metabolic diseases that occur globally, such as diabetes, hypertension, and heart disease [7] . Obesity is characterized by increased adipose tissue mass that results from both increased fat cell number and increased fat cell size [4] . The amount of adipose tissue mass can be regulated by the inhibition of adipogenesis from fibroblastic preadipocyte to mature adipocyte [22] and induction of lipolysis in adipose tissues. Therefore, adipocyte differentiation by modulation of adipogenesis and lipogenesis has been a target of antiobesity strategies [2] .
3T3-L1 preadipocyte is a well-established cell line used to study adipogenic differentiation [26] . Adipocyte differentiation is an intricate course accompanied by changes in morphology, hormone sensitivity, and gene expression. Confluent preadipocytes go into adipocytes through the clonal expansion, growth arrest, and expression of adipocyte markers by hormonal induction [3] . Several transcription factors have been shown to be important players in adipocyte differentiation. CCAAT/enhancer-binding protein (C/EBP) α and peroxisome proliferator-activated receptor (PPAR) γ play essential roles in adipogenic differentiation through transcription of various genes responsible for fat transport and accumulation [3, 20, 27] . In the early phase of adipocyte differentiation, the expression of PPARγ is induced by two transcription factors, C/EBPβ and C/ EBPδ, which leads to the expression of C/EBPα. PPARγ and C/EBPα cross-regulate each other to maintain their gene expression and critically regulate the expression of adipose-specific genes that are involved in developing the adipose phenotype during adipocyte differentiation. In addition, they synergistically transactivate downstream adipocyte-specific gene expression including ap2 (FABP4), glucose transporter type 4 (GLUT4), lipoprotein lipase (LPL), and insulin receptor, all of these involved in the adipose phenotype, as well as glucose and lipid metabolism in mature adipocytes [9, 23, 25] . The CDK inhibitor, p21, is involved in the distinct states of growth arrest [18] . p21 degrades as cells progress through the S phase and elevates to reach the highest level at the beginning of terminal differentiation [18] .
Widdrol, a natural and crystalline substance, is an odorant derivative contained in various plants such as the Juniperus sp., including J. chinensis [15, 31] . Recently, widdrol was reported to possess antifungal and antitumor activities [14, 30] . However, its biological and pharmacological effects are still poorly defined. Furthermore, there are no reports of inhibitory effects of widdrol on adipogenic differentiation. In the present study, we hypothesized that widdrol can inhibit adipocyte differentiation through cell-cycle arrest in 3T3-L1 cells. Because the direct effects of widdrol on adipogenic differentiation and the regulatory mechanism in adipocytes have remained unclear until now, this study was designed to characterize the effects of widdrol on adipogenic differentiation of 3T3-L1 cells and its inhibitory mechanism on adipocyte differentiation at the cellular and molecular levels.
MATERIALS AND METHODS

Materials
3T3-L1 fibroblast cells were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA). 3-Isobutyl-methylxanthine (IBMX), dexamethasone, insulin, Dulbecco's modified Eagle's medium (DMEM, Gibco, Carlsbad, CA, USA), gentamycin, and Oil Red O were purchased from Sigma-Aldrich Chemical Co. (St. Louis, MO, USA).
Cell Culture and Differentiation Induction 3T3-L1 mouse embryo fibroblasts were cultured as described elsewhere [11] . Briefly, cells were cultured in DMEM (SigmaAldrich Co., St. Louis, MO, USA) containing 10% bovine calf serum (BCS; WelGENE Inc., Daegu, Korea) until the cells were confluent. Two days after confluency was achieved (Day 0), the cells were stimulated to differentiate with DMEM containing 10% fetal bovine serum (FBS; Omega Scientific, Inc., Tarzana, CA, USA), 10 µg/ml insulin, 0.5 mM IBMX, and 0.25 µM dexamethasone for 2 days (Day 2). Cell were then maintained in 10% FBS/DMEM with 10 µg/ml insulin for the next 6 days (Day 8), at which time >90% of cells were mature adipocytes with accumulated fat droplets. All media contained 0.01% gentamycin. Cells were maintained at 37 o C in a humidified 5% CO 2 atmosphere.
Cell Viability
Cell viability was assessed using the Premix WST-1 Cell Proliferation Assay System (Takara, Otsu, Shiga, Japan). WST is a water-soluble formazan upon metabolically active cells, allowing a direct colorimetric measurement of cell viability and proliferation. In brief, 3T3-L1 preadipocyte cells were seeded in 96-well plates (5×10 3 cells/well) and allowed to adhere overnight. After 24 h, culture media containing widdrol (0, 9, 18, 36, 72, 144, and 288 µM) was added to each well and the cells were incubated 48 h. After incubation for 48 h, 20 µl of WST solution (10 mg/ml) was added followed by 30 min additional incubation. Then the absorbance was measured in a microplate reader at 450 nm and cell viability was calculated.
Proliferation Assay
Adipocyte proliferation was assessed by the trypan blue dye exclusion assay [13] in quadruplicate using a hemocytometer to determine whether widdrol affects the mitotic clonal expansion on adipocytes. The cells were trypsinized, followed by washing with phosphate-buffered saline (PBS). Trypan blue dye solution was then added to the cell suspension. Viable cells were counted with a hemocytometer.
Oil Red O Staining
To observe the effects of widdrol on adipocye differentiation, adipocytes undergoing 0.5 mM IBMX, and 0.25 µM dexamethasone, 10 µg/ml insulin (MDI)-induced differentiation were treated with various doses of widdrol (0, 5, 23, 45, 68, and 90 µM). After completing differentiation, the cells were washed twice with PBS and then with 10% fresh formalin for at least 30 min at room temperature. After the 10% fresh formalin was removed, the cells were washed with 60% isopropanol. Cells were stained with Oil Red O dye (saturated Oil Red O dye in six parts of isopropanol and four parts of water) for 20 min at room temperature. The staining dye contained in the cells was extracted with 100% isopropanol and measured with a spectrophotometer at 500 nm. The values were calculated as percentages of the control cells (0.1% DMSO treated).
Flow Cytometry Analysis of Cell Cycle 3T3-L1 cells were seeded in 6-well plates (5×10 4 cells/well), and then post confluent 3T3-L1 preadipocytes were treated with MDI in the presence or absence of 68 µM widdrol for 14 and 18 h. The cells were then harvested, washed once with cold PBS, fixed in icecold 80% ethanol, and stored at 4 o C. Prior to analysis, the cells were washed again with PBS and suspended in 1 ml of a cold propidium iodide (PI) solution containing 100 µg/ml RNase A, 50 µg/ml PI, 0.1% (w/v) sodium citrate, and 0.1% (v/v) NP-40. Following this, cells were incubated on ice for an additional 30 min in the dark. Next, flow cytometry was conducted (FACS Caliber, Becton, Dickinson & Co., Franklin Lakes, NJ, USA) and the CellQuest software was used to determine the relative DNA content based on the presence of red fluorescence.
Protein Extraction and Western Blotting
Cell lysates were prepared in CSK buffer (10 mM Pipes, pH 6.8, 100 mM NaCl, 1 mM MgCl 2 , 1 mM EGTA, 1 mM dithiothreitol, and 1 mM phenylmethanesulfonyl fluoride) containing 0.1% Triton X-100, 1 mM ATP, and proteinase inhibitors (BD Pharminogen, San Diego, CA, USA) on ice for 15 min. The lysates were centrifuged at 20,000 ×g for 30 min and the protein concentration of the supernatant was determined using a BCA protein assay kit (Bio-Rad Laboratories Inc., Hercules, CA, USA). Equal amounts of protein were separated by SDS-PAGE and transferred to a PVDF membrane (Pall Corporation, Port Washington, NY, USA). The membrane was incubated at 4 o C for 10 h with primary antibodies in blocking solution (Blockace; Dai-Nippon, Osaka, Japan). After washing with Tris-buffered saline (TBS; 50 mM Tris/HCl, pH 7.5, and 0.15 M NaCl) containing 0.1% Triton X-100, the membrane was incubated with peroxidase-conjugated secondary antibodies (Thermo Fisher Scientific, Inc., Rockford, IL, USA). The immunoreacted proteins were detected using a chemiluminescence system (SuperSignal West Femto Maximum Sensitivity Substrate; Thermo Fisher Scientific Inc., Waltham, MA, USA), and the level of reactivity was quantified (Fluorchem TM 5500; Alpha Innotech, Santa Clara, CA, USA).
Statistical Analysis
Statistical analysis was performed using the Student's t-test. Data were expressed as means ± standard deviation (SD). Statistical significance was represented with an asterisk for P values <0.05 and two asterisks for P values <0.01.
RESULTS
Cytotoxicity of Widdrol on 3T3-L1 Cells
To investigate the cytotoxic effect of widdrol on 3T3-L1 cells, cell viability was determined by the WST assay. The cells were seeded into wells of a 96-well plate and cells were treated with various concentrations of widdrol (0, 9, 18, 36, 72, 144, and 288 µM) for 48 h. Cells treated with 0.1% DMSO were used as a control. As shown in Table 1 , widdrol obviously had no significant cytotoxicity against preadipocyte 3T3-L1 cells as well as SC-1 mouse embryo fibroblast cells.
Inhibitory Effect of Widdrol on Lipid Accumulation in 3T3-L1 Adipocytes
To identify the inhibitory effect of widdrol on adipogenesis, the adipocyte differentiation can be monitored by the microscopically apparent intracellular accumulation of lipid droplets. As previously indicated, confluent 3T3-L1 preadipocytes with MDI (0.5 mM IBMX, 0.25 µM dexamethasone, and 10 µg/ml insulin) initiated the adipocyte differentiation. To investigate the potential effect and arrange the optimal dose of widdrol treatment, cells were treated with various doses of widdrol (0, 5, 23, 45, 68, and 90 µM) during MDI-induced differentiation. After 48 h, the medium was changed to post-differentiation medium (i.e., containing only 10 µg/ml insulin), which was replaced every 2 days. After 6 days of in vitro adipogenic induction, the cells were fixed with 10% formalin for 1 h, and then stained with Oil Red O in order to measure the lipid accumulation, a major marker of adipogenesis. In this study, differences in the efficiency of lipid droplet formation between native and widdrol-treated cells were quantified by determining the number of stained lipid droplets. As shown in Fig. 1A , widdrol clearly inhibited lipid droplet accumulation in the cytoplasm in a dose-dependent manner. In particular, 90 µM widdrol did not affect cell viability (Table 1) , but inhibited the intracellular lipid droplet accumulation up to 75.6 ± 0.8%, as compared with the MDI-treated positive controls (*P<0.05, **P<0.01) (Fig. 1B) . These experimental results clearly show that the inhibitory effect of widdrol on lipid accumulation is not involved in the cytotoxic effect of widdrol on 3T3-L1 adipocytes.
Widdrol Affects the Proliferation Stage of the Adipogenic Process
The adipogenic process includes both preadipocyte proliferation and adipogenic differentiation [12, 32] . When growth-arrested 3T3-L1 preadipocytes are stimulated by hormonal inducer such as MDI, they reenter the cell cycle and undergo approximately two rounds of cell division. Because widdrol inhibited adipocyte differentiation at an early stage, it was of interest to estimate the effect of widdrol on the proliferation of 3T3-L1 preadipocytes induced by MDI. Two days post-confluent 3T3-L1 cells were incubated in a medium containing MDI with DMSO (vehicle) or various doses of widdrol (5, 23, 45, 68, and 90 µM) for 24 and 48 h. As shown in Fig. 2 , when postconfluent 3T3-L1 cells were incubated in a medium containing MDI, the cell number increased during the clonal expansion phase as a function of time, at least up to 48 h. In contrast, widdrol significantly inhibited MDIinduced mitosis in a dose-dependent manner, compared with MDI alone.
Widdrol Causes Cell-Cycle Arrest in 3T3-L1 Adipocyte Cells Proliferation of preadipocytes is a prerequisite for differentiation from 3T3-L1 preadipocytes into mature adipocytes. MDI initiates this mitosis, and adipogenic differentiation occurs after proliferation. In the present study, post-confluent 3T3-L1 preadipocytes were treated with MDI in the presence (68 µM) or absence of widdrol for 14 and 18 h. To observe the effect of widdrol on cell mitosis after MDIinduced adipogenic differentiation, the cells were then harvested and the cell cycle was analyzed by FACS. As shown in Fig. 3 , the cell-cycle analysis clearly indicated that MDI initiated cell-cycle progression, whereas widdrol actively induced cell-cycle arrest at the G1-S phase transition, causing cells to remain in the preadipocyte state. This result was consistent with the data summarized in Fig. 2 indicating widdrol-mediated inhibition of MDI- induced mitosis. Therefore, these findings distinctly suggest that widdrol blocks adipogenic differentiation through inhibition of mitotic clonal expansion by G1 arrest.
Effect of Widdrol on the Expression of Adipogenic Transcription Factors in Adipocyte Differentiation
To investigate whether widdrol could affect the expression of adipogenic transcription factors in adipocyte differentiation, Western blot analysis was employed. Two types of analyses were performed. In the first experiment, 2 days post-confluent 3T3-L1 preadipocytes (Day 0) were stimulated for 2 days with MDI-containing medium containing various concentrations (0, 5, 23, 45, 68, and 90 µM) of widdrol. On Day 2, the MDI medium was replaced with DMEM supplemented with 10% FBS and containing 10 µg/ml insulin and the indicated concentration of widdrol. The medium was changed at Days 2, 4, and 6. Cells were harvested at Day 8 and analyzed by Western blotting. As shown in Fig. 4A , widdrol co-treatment markedly attenuated adipogenic transcription factors such as C/EBPα and PPARγ in a dosedependent manner. C/EBPα and PPARγ cross-regulate each other to maintain their gene expression and synergistically transactivate the expression of adipose-specific genes that are involved in developing the adipose phenotype during adipocyte differentiation [9, 23, 25] . Therefore, these findings distinctly suggest that widdrol inhibits adipogenic differentiation through regulation of adipogenic transcription factors such as C/EBPα and PPARγ. In the second experiment, to identify whether widdrol could induce inhibition of mitotic clonal expansion and G1 3T3-L1 preadipocytes with MDI induced the differentiation into adipocyte as described in Materials and Methods. Cells were treated with various doses of widdrol (0, 5, 23, 45, 68, and 90 µM) during MDI-induced differentiation. After 48 h, the medium was changed to post-differentiation medium (i.e., containing only 10 µg/ml insulin), which was replaced every 2 days. After 6 days, the cells were fixed with 10% formalin for 1 h and then stained with Oil Red O. Stained intracellular oil droplets were eluted with 100% isopropanol (A) and quantified by spectrophotometrical analysis at 500 nm (B). The values were calculated as percentages of the control cells (0.1% DMSO treated) and expressed as the mean ± SD. *P<0.05 and **P<0.01 by Student's t-test compared with only MDI-treated cells.
arrest at an early stage of adipocyte differentiation, 2 days post-confluent cells were treated with DMSO (vehicle) or various concentrations (0, 5, 23, 45, 68, and 90 µM) of widdrol in a medium containing MDI for 48 h. In the early phase of adipocyte differentiation, C/EBPβ is an important player in adipocyte differentiation by functioning as a transcriptional activator of adipocyte genes, and induces the expression of PPARγ. PPARγ also plays a vital role in adipogenic differentiation through transcription of various genes responsible for fat transport and accumulation [9, 23] . As shown in Fig. 4B , widdrol co-treatment significantly decreased the expression of C/EBPβ in a dose-dependent manner. On the other hand, the expression level of C/ EBPα and PPARγ were slightly decreased compared with that of C/EBPβ after MDI treatment for 48 h. This result was consistent with the report that C/EBPα and PPARγ are involved in adipocyte differentiation at a late stage [9, 23] .
Cell-cycle-related protein analysis also supported G1 arrest by widdrol. Sustained expression of the CDK inhibitor p21 resulted in cell-cycle G1 arrest [24] . In an effort to assess the inhibitory mechanism of widdrol on adipogenesis, p21 expression was assessed. As shown in Fig. 4B , the level of p21 decreased during differentiation, but this decrease was restored by widdrol co-treatment. Retinoblastoma protein (Rb) was phosphorylated during differentiation and widdrol inhibited this phosphorylation. Rb is an important regulator of the G1 to S phase transition in the cell cycle, and represses gene transcription required for this transition by interacting with E2F transcription factors. Moreover, Rb is regulated by CDK phosphorylation [5, 10] . Widdrol co-treatment markedly attenuated the expression of CDK2 and E2F1, but it did not affect the level of Cyclin E. Based on these results, p21 and Rb seem to be involved in antimitotic regulation by widdrol. It is thought that widdrol induces the active expression of p21 and this increase inhibits phosphorylation of Rb and activation of its downstream mediators, CDK2 and E2F1. Therefore, these results clearly demonstrated that widdrol blocks adipogenic differentiation through inhibition of mitotic clonal expansion and G1 arrest at an early stage of adipocyte differentiation.
DISCUSSION
Obesity is no longer considered to be simply a cosmetic problem. Rather, it is clear that obesity is associated with the development of many metabolic diseases such as type II diabetes, hypertension, osteoarthritis, heart disease, dyslipidemia, and myocardial infarction, and that the global prevalence of obesity is greatly increasing [16, 28] . Obesity is characterized at the cellular level by an increase in the number and size of adipocytes differentiated from fibroblastic preadipocytes in adipose tissue [8] . There are several proposed strategies for treating obesity, including balanced energy intake and expenditure, decreased preadipocyte differentiation, decreased lipogenesis, increased lipolysis, and induction of adipocyte apoptosis [1, 29] . Specifically, blocking adipocyte differentiation is an important antiobesity strategy, because obesity is caused not only by hypertrophy of adipocytes, but also by adipocyte hyperplasia [2] . The 3T3-L1 adipocyte differentiation system is the most widely used to study adipocyte differentiation [32] . Adipocyte differentiation is an intricate course accompanied by changes in morphology, hormone sensitivity, and gene expression. Confluent preadipocytes progress to adipocytes through the clonal expansion, growth arrest, and expression of adipocyte markers by hormonal induction [3] .
The utilization of anti-adipogenic compounds from natural sources could be helpful in reducing obesity and its consequent side effects [17, 19, 21] . Widdrol, a crystalline, natural substance, is an odorant derivative contained in various plants such as the Juniperus sp., including J. chinensis [15, 31] . Previously, we reported that widdrol possesses antitumor activity [14] . However, its biological and pharmacological effects are still poorly defined. Specifically, there has hitherto been no report of inhibitory effects of widdrol on adipogenic differentiation. Therefore, this study was undertaken to investigate the effects of widdrol on adipogenic differentiation of 3T3-L1 cells and its inhibitory mechanism on adipocyte differentiation at the cellular and molecular levels.
The present study demonstrated the inhibitory effect of widdrol on lipid accumulation in 3T3-L1 adipocytes. The accumulation of cytoplasmic lipid droplets is a major marker of adipogenesis. Thus, this study tested the changes of lipid droplets by widdrol treatment during adipocyte differentiation. Widdrol co-treatment dramatically inhibited the formation of cytoplasmic lipid droplets in a dosedependent manner. In particular, 90 µM widdrol inhibited the intracellular accumulation of lipid droplets by up to 75.6 ± 0.8% of the MDI-treated positive controls (Fig. 1) . To reconfirm whether the inhibitory effect of widdrol on lipid accumulation was involved in the cytotoxic effect of widdrol on 3T3-L1 adipocytes, cell viability was measured by an established WST assay. Widdrol exhibited no significant cytotoxicity against preadipocyte 3T3-L1 cells and SC-1 mouse embryo fibroblast cells (Table 1) . Therefore, the inhibitory effect of widdrol on adipocyte differentiation is not completely involved in the cytotoxicity of widdrol on 3T3-L1 adipocytes.
This study also investigated the inhibitory mechanism of widdrol on adipocyte differentiation at the cellular and molecular levels. Widdrol affected the proliferation stage of the adipogenic process by regulating the cell cycle in the early phase of adipocyte differentiation. The adipogenic process includes both preadipocyte proliferation and adipogenic differentiation [12, 32] . When growth-arrested 3T3-L1 preadipocytes are stimulated by an hormonal inducer such as MDI, they reenter the cell cycle and undergo approximately two rounds of cell division. Presently, widdrol significantly inhibited MDI-induced mitosis in a dosedependent manner, compared with MDI alone (Fig. 2) . Therefore, widdrol inhibited adipocyte differentiation at an early stage. FACS data on cell-cycle analysis supported the effect of widdrol on preadipocyte proliferation. Generally, MDI induced the growth-arrested preadipocytes to initiate cell-cycle progression. On the other hand, widdrol blocked the cell cycle at the G1/S transition and caused cells to remain in the preadipocyte state (Fig. 3) . The results are entirely consistent with the widdrol-mediated blockage of adipogenic differentiation through the inhibition of mitotic clonal expansion by G1 arrest.
Adipogenesis requires a network of transcription factors and signaling pathways, which contributes to the expression of genes required for the development of the adipocyte phenotype [6] . Several transcription factors have been shown to be important players in adipocyte differentiation. C/EBPα and PPARγ, two adipogenic transcription factors, play key roles in adipocyte differentiation. In particular, the essential transcription factors, C/EBPβ and C/EBPδ, are expressed after exposure of growth-arrested preadipocytes to adipogenic inducers [6] . The C/EBP family members then facilitate PPARγ and C/EBPα expression through their interactions with the DNA element(s) located in the target genes [6] . Thus, C/EBPβ plays an important role in the clonal expansion of preadipocytes [32] . Expression of C/EBPα and PPARγ is elevated during the differentiation process and is needed for the life of the mature adipocyte. C/EBPα and PPARγ synergistically transactivate the downstream adipocyte-specific gene expression including ap2 (FABP4), GLUT4, LPL, and insulin receptor; all of these are involved in the adipose phenotype, as well as glucose and lipid metabolism [9] . This study next investigated whether widdrol affects the expression of adipogenic transcription factors in adipocyte differentiation. In adipocyte differentiation at a late stage, widdrol markedly attenuated adipogenic transcription factors such as C/EBPα and PPARγ in a dose-dependent manner (Fig. 4A) . In the early phase of adipocyte differentiation, widdrol distinctly decreased C/EBPβ in dose-dependent manner (Fig. 4B) . However, widdrol did not affect the level of C/EBPα and PPARγ in the early phase of adipocyte differentiation (Fig. 4B) . This result was consistent with the report that PPARγ is involved in adipocyte differentiation at a late stage [9, 23] .
Cell-cycle protein analysis also supported G1 arrest by widdrol. p21 and Rb were modulated by widdrol cotreatment. Once the cell-cycle progression was initiated after MDI treatment, CDK inhibitor p21 expression was decreased. However, this reduction was restored by widdrol co-treatment (Fig. 4B) . Rb is an important regulator of the G1 to S phase transition in the cell cycle and represses the gene transcription required for this transition by interacting with E2F transcription factors [10] . Furthermore, Rb is regulated by CDK phosphorylation, and the Rb phosphorylation state continues from the late G1 phase of the cell cycle until mitosis [5] . The present study revealed that the onset of differentiation initiated Rb phosphorylation, but widdrol inhibited this phosphorylation. Based on these results, p21 and Rb seem to be involved in antimitotic regulation by widdrol. However, further research is needed to identify the complex mechanisms that mediate the regulation of adipogenesis by widdrol.
In summary, this report suggests that widdrol blocks preadipocyte growth and differentiation through the inhibition of mitotic clonal expansion by p21-and Rb-dependent G1 arrest in the early phase of adipocyte differentiation. This inhibitory effect of widdrol on adipogenic differentiation is steadily maintained to the late phage of adipocyte differentiation. The mechanisms by which widdrol regulates adipogenesis include the inhibition of lipid accumulation and expression of the adipogenic transcription factors such as C/EBPα, PPARγ, C/EBPβ, and E2F1. Therefore, these results may be of help in understanding the basic biology of the anti-adipogenic process, and developing the potent anti-adipogenic modulators that are crucial in reducing obesity.
